{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NF-\u03baB", "TLR4", "gut microbiota", "kaempferol", "lipopolysaccharide", "ulcerative colitis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34367139", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "25"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "22"}], "Language": ["eng"], "ELocationID": ["679897", "10.3389/fimmu.2021.679897"], "Journal": {"ISSN": "1664-3224", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in immunology", "ISOAbbreviation": "Front Immunol"}, "ArticleTitle": "Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-\u03baB Axis.", "Pagination": {"StartPage": "679897", "MedlinePgn": "679897"}, "Abstract": {"AbstractText": ["Intestinal microbiota dysbiosis is an established characteristic of ulcerative colitis (UC). Regulating the gut microbiota is an attractive alternative UC treatment strategy, considering the potential adverse effects of synthetic drugs used to treat UC. Kaempferol (Kae) is an anti-inflammatory and antioxidant flavonoid derived from a variety of medicinal plants. In this study, we determined the efficacy and mechanism of action of Kae as an anti-UC agent in dextran sulfate sodium (DSS)-induced colitis mice. DSS challenge in a mouse model of UC led to weight loss, diarrhea accompanied by mucous and blood, histological abnormalities, and shortening of the colon, all of which were significantly alleviated by pretreatment with Kae. In addition, intestinal permeability was shown to improve using fluorescein isothiocyanate (FITC)-dextran administration. DSS-induced destruction of the intestinal barrier was also significantly prevented by Kae administration <i>via</i> increases in the levels of ZO-1, occludin, and claudin-1. Furthermore, Kae pretreatment decreased the levels of <i>IL-1\u03b2, IL-6</i>, and <i>TNF-\u03b1</i> and downregulated transcription of an array of inflammatory signaling molecules, while it increased <i>IL-10</i> mRNA expression. Notably, Kae reshaped the intestinal microbiome by elevating the <i>Firmicutes</i> to <i>Bacteroidetes</i> ratio; increasing the linear discriminant analysis scores of beneficial bacteria, such as <i>Prevotellaceae</i> and <i>Ruminococcaceae</i>; and reducing the richness of <i>Proteobacteria</i> in DSS-challenged mice. There was also an evident shift in the profile of fecal metabolites in the Kae treatment group. Serum LPS levels and downstream TLR4-NF-\u03baB signaling were downregulated by Kae supplementation. Moreover, fecal microbiota transplantation from Kae-treated mice to the DSS-induced mice confirmed the effects of Kae on modulating the gut microbiota to alleviate UC. Therefore, Kae may exert protective effects against colitis mice through regulating the gut microbiota and TLR4-related signaling pathways. This study demonstrates the anti-UC effects of Kae and its potential therapeutic mechanisms, and offers novel insights into the prevention of inflammatory diseases using natural products."], "CopyrightInformation": "Copyright \u00a9 2021 Qu, Li, Xu, Zhao, Wu, Wang and Xie."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inner Mongolia Clinical College, Inner Mongolia Medical University, Hohhot, China."}, {"Identifier": [], "Affiliation": "Clinical Laboratory, Inner Mongolia People's Hospital, Hohhot, China."}], "LastName": "Qu", "ForeName": "Yifan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Life Science, Inner Mongolia Agricultural University, Hohhot, China."}], "LastName": "Li", "ForeName": "Xinyi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Inner Mongolia Clinical College, Inner Mongolia Medical University, Hohhot, China."}], "LastName": "Xu", "ForeName": "Fengying", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Life Science, Inner Mongolia Agricultural University, Hohhot, China."}], "LastName": "Zhao", "ForeName": "Shimin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Life Science, Inner Mongolia Agricultural University, Hohhot, China."}], "LastName": "Wu", "ForeName": "Xuemei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Life Science, Inner Mongolia Agricultural University, Hohhot, China."}], "LastName": "Wang", "ForeName": "Yuzhen", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Laboratory, Inner Mongolia People's Hospital, Hohhot, China."}], "LastName": "Xie", "ForeName": "Jiming", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Immunol", "NlmUniqueID": "101560960", "ISSNLinking": "1664-3224"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Kaempferols"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Ribosomal, 16S"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "731P2LE49E", "NameOfSubstance": "kaempferol"}, {"RegistryNumber": "9042-14-2", "NameOfSubstance": "Dextran Sulfate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Biomarkers"}, {"QualifierName": ["etiology", "metabolism", "pathology", "therapy"], "DescriptorName": "Colitis"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Dextran Sulfate"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Fecal Microbiota Transplantation"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["metabolism", "microbiology"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Kaempferols"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Permeability"}, {"QualifierName": [], "DescriptorName": "RNA, Ribosomal, 16S"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Toll-Like Receptor 4"}], "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. . Ulcerative Colitis. Nat Rev Dis Primers (2020) 6:74. \u00a010.1038/s41572-020-0205-x", "ArticleIdList": ["10.1038/s41572-020-0205-x", "32913180"]}, {"Citation": "Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel J-F. Ulcerative Colitis. Lancet (2017) 389:1756\u201370. 10.1016/S0140-6736(16)32126-2", "ArticleIdList": ["10.1016/S0140-6736(16)32126-2", "PMC6487890", "27914657"]}, {"Citation": "Ananthakrishnan AN. Epidemiology and Risk Factors for IBD. Nat Rev Gastroenterol Hepatol (2015) 12:205\u201317. 10.1038/nrgastro.2015.34", "ArticleIdList": ["10.1038/nrgastro.2015.34", "25732745"]}, {"Citation": "de Souza HS, Fiocchi C. Immunopathogenesis of IBD: Current State of the Art. Nat Rev Gastroenterol Hepatol (2016) 13:13\u201327. 10.1038/nrgastro.2015.186", "ArticleIdList": ["10.1038/nrgastro.2015.186", "26627550"]}, {"Citation": "Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, et al. . Relationship Between Intestinal Microbiota and Ulcerative Colitis: Mechanisms and Clinical Application of Probiotics and Fecal Microbiota Transplantation. World J Gastroenterol (2018) 24:5\u201314. 10.3748/wjg.v24.i1.5", "ArticleIdList": ["10.3748/wjg.v24.i1.5", "PMC5757125", "29358877"]}, {"Citation": "Linares V, Alonso V, Domingo JL. Oxidative Stress as a Mechanism Underlying Sulfasalazine-Induced Toxicity. Expert Opin Drug Saf (2011) 10:253\u201363. 10.1517/14740338.2011.529898", "ArticleIdList": ["10.1517/14740338.2011.529898", "21219240"]}, {"Citation": "Salice M, Rizzello F, Calabrese C, Calandrini L, Gionchetti P. A Current Overview of Corticosteroid Use in Active Ulcerative Colitis. Expert Rev Gastroenterol Hepatol (2019) 13:557\u201361. 10.1080/17474124.2019.1604219", "ArticleIdList": ["10.1080/17474124.2019.1604219", "30947569"]}, {"Citation": "Kumar A. Phytochemistry, Pharmacological Activities and Uses of Traditional Medicinal Plant Kaempferia Galanga L. - An Overview. J Ethnopharmacol (2020) 253:112667. \u00a010.1016/j.jep.2020.112667", "ArticleIdList": ["10.1016/j.jep.2020.112667", "32061673"]}, {"Citation": "Rajendran P, Rengarajan T, Nandakumar N, Palaniswami R, Nishigaki Y, Nishigaki I. Kaempferol, a Potential Cytostatic and Cure for Inflammatory Disorders. Eur J Med Chem (2014) 86:103\u201312. 10.1016/j.ejmech.2014.08.011", "ArticleIdList": ["10.1016/j.ejmech.2014.08.011", "25147152"]}, {"Citation": "Hung TW, Chen PN, Wu HC, Wu SW, Tsai PY, Hsieh YS, et al. . Kaempferol Inhibits the Invasion and Migration of Renal Cancer Cells Through the Downregulation of AKT and FAK Pathways. Int J Med Sci (2017) 14:984\u201393. 10.7150/ijms.20336", "ArticleIdList": ["10.7150/ijms.20336", "PMC5599922", "28924370"]}, {"Citation": "Yang YL, Cheng X, Li WH, Liu M, Wang YH, Du GH. Kaempferol Attenuates LPS-Induced Striatum Injury in Mice Involving Anti-Neuroinflammation, Maintaining BBB Integrity, and Down-Regulating the HMGB1/TLR4 Pathway. Int J Mol Sci (2019) 20:491. \u00a010.3390/ijms20030491", "ArticleIdList": ["10.3390/ijms20030491", "PMC6386879", "30678325"]}, {"Citation": "Kim JM, Lee EK, Kim DH, Yu BP, Chung HY. Kaempferol Modulates Pro-Inflammatory NF-kappaB Activation by Suppressing Advanced Glycation Endproducts-Induced NADPH Oxidase. Age (Dordr) (2010) 32:197\u2013208. 10.1007/s11357-009-9124-1", "ArticleIdList": ["10.1007/s11357-009-9124-1", "PMC2861750", "20431987"]}, {"Citation": "Tang XL, Liu JX, Dong W, Li P, Li L, Hou JC, et al. . Protective Effect of Kaempferol on LPS Plus ATP-Induced Inflammatory Response in Cardiac Fibroblasts. Inflammation (2015) 38:94\u2013101. 10.1007/s10753-014-0011-2", "ArticleIdList": ["10.1007/s10753-014-0011-2", "25189464"]}, {"Citation": "Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A, Azizi F. Non-Soya Legume-Based Therapeutic Lifestyle Change Diet Reduces Inflammatory Status in Diabetic Patients: A Randomised Cross-Over Clinical Trial. Br J Nutr (2015) 114:213\u20139. 10.1017/S0007114515001725", "ArticleIdList": ["10.1017/S0007114515001725", "26077375"]}, {"Citation": "Park MY, Ji GE, Sung MK. Dietary Kaempferol Suppresses Inflammation of Dextran Sulfate Sodium-Induced Colitis in Mice. Dig Dis Sci (2012) 57:355\u201363. 10.1007/s10620-011-1883-8", "ArticleIdList": ["10.1007/s10620-011-1883-8", "21901258"]}, {"Citation": "Eichele DD, Kharbanda KK. Dextran Sodium Sulfate Colitis Murine Model: An Indispensable Tool for Advancing Our Understanding of Inflammatory Bowel Diseases Pathogenesis. World J Gastroenterol (2017) 23:6016\u201329. 10.3748/wjg.v23.i33.6016", "ArticleIdList": ["10.3748/wjg.v23.i33.6016", "PMC5597494", "28970718"]}, {"Citation": "Munyaka PM, Rabbi MF, Khafipour E, Ghia JE. Acute Dextran Sulfate Sodium (DSS)-Induced Colitis Promotes Gut Microbial Dysbiosis in Mice. J Basic Microbiol (2016) 56:986\u201398. 10.1002/jobm.201500726", "ArticleIdList": ["10.1002/jobm.201500726", "27112251"]}, {"Citation": "Ji J, Ge X, Chen Y, Zhu B, Wu Q, Zhang J, et al. . Daphnetin Ameliorates Experimental Colitis by Modulating Microbiota Composition and Treg/Th17 Balance. FASEB J (2019) 33:9308\u201322. 10.1096/fj.201802659RR", "ArticleIdList": ["10.1096/fj.201802659RR", "31145641"]}, {"Citation": "He Y, Li X, Yu H, Ge Y, Liu Y, Qin X, et al. . The Functional Role of Fecal Microbiota Transplantation on Dextran Sulfate Sodium-Induced Colitis in Mice. Front Cell Infect Microbiol (2019) 9:393. \u00a010.3389/fcimb.2019.00393", "ArticleIdList": ["10.3389/fcimb.2019.00393", "PMC6873233", "31803633"]}, {"Citation": "Wang L, An J, Song S, Mei M, Li W, Ding F, et al. . Electroacupuncture Preserves Intestinal Barrier Integrity Through Modulating the Gut Microbiota in DSS-Induced Chronic Colitis. Life Sci (2020) 261:118473. \u00a010.1016/j.lfs.2020.118473", "ArticleIdList": ["10.1016/j.lfs.2020.118473", "32971101"]}, {"Citation": "Hu J, Huang H, Che Y, Ding C, Zhang L, Wang Y, et al. . Qingchang Huashi Formula Attenuates DSS-Induced Colitis in Mice by Restoring Gut Microbiota-Metabolism Homeostasis and Goblet Cell Function. J Ethnopharmacol (2020) 266:113394. \u00a010.1016/j.jep.2020.113394", "ArticleIdList": ["10.1016/j.jep.2020.113394", "32941971"]}, {"Citation": "Wu M, Li P, An Y, Ren J, Yan D, Cui J, et al. . Phloretin Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating the Gut Microbiota. Pharmacol Res (2019) 150:104489. \u00a010.1016/j.phrs.2019.104489", "ArticleIdList": ["10.1016/j.phrs.2019.104489", "31689519"]}, {"Citation": "Bolger AM, Lohse M, Usadel B. Trimmomatic: A Flexible Trimmer for Illumina Sequence Data. Bioinformatics (2014) 30:2114\u201320. 10.1093/bioinformatics/btu170", "ArticleIdList": ["10.1093/bioinformatics/btu170", "PMC4103590", "24695404"]}, {"Citation": "Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. FLASH Assembly of TALENs for High-Throughput Genome Editing. Nat Biotechnol (2012) 30:460\u20135. 10.1038/nbt.2170", "ArticleIdList": ["10.1038/nbt.2170", "PMC3558947", "22484455"]}, {"Citation": "Rognes T, Flouri T, Nichols B, Quince C, Mahe F. VSEARCH: A Versatile Open Source Tool for Metagenomics. PeerJ (2016) 4:e2584. \u00a010.7717/peerj.2584", "ArticleIdList": ["10.7717/peerj.2584", "PMC5075697", "27781170"]}, {"Citation": "Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. . QIIME Allows Analysis of High-Throughput Community Sequencing Data. Nat Methods (2010) 7:335\u20136. \u00a010.1038/nmeth.f.303", "ArticleIdList": ["10.1038/nmeth.f.303", "PMC3156573", "20383131"]}, {"Citation": "Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform. Appl Environ Microbiol (2013) 79:5112\u201320. \u00a010.1128/AEM.01043-13", "ArticleIdList": ["10.1128/AEM.01043-13", "PMC3753973", "23793624"]}, {"Citation": "Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. . Metagenomic Biomarker Discovery and Explanation. Genome Biol (2011) 12:R60. \u00a010.1186/gb-2011-12-6-r60", "ArticleIdList": ["10.1186/gb-2011-12-6-r60", "PMC3218848", "21702898"]}, {"Citation": "Volynets V, Reichold A, Bardos G, Rings A, Bleich A, Bischoff SC. Assessment of the Intestinal Barrier With Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice. Dig Dis Sci (2016) 61:737\u201346. \u00a010.1007/s10620-015-3935-y", "ArticleIdList": ["10.1007/s10620-015-3935-y", "26520109"]}, {"Citation": "Seyed Tabib NS, Madgwick M, Sudhakar P, Verstockt B, Korcsmaros T, Vermeire S. Big Data in IBD: Big Progress for Clinical Practice. Gut (2020) 69(8):1520\u201332. \u00a010.1136/gutjnl-2019-320065", "ArticleIdList": ["10.1136/gutjnl-2019-320065", "PMC7398484", "32111636"]}, {"Citation": "de Lange KM, Barrett JC. Understanding Inflammatory Bowel Disease Via Immunogenetics. J Autoimmun (2015) 64:91\u2013100. 10.1016/j.jaut.2015.07.013", "ArticleIdList": ["10.1016/j.jaut.2015.07.013", "26257098"]}, {"Citation": "Schirmer M, Garner A, Vlamakis H, Xavier RJ. Microbial Genes and Pathways in Inflammatory Bowel Disease. Nat Rev Microbiol (2019) 17:497\u2013511. 10.1038/s41579-019-0213-6", "ArticleIdList": ["10.1038/s41579-019-0213-6", "PMC6759048", "31249397"]}, {"Citation": "Wang F, Zhao HY, Zhang ST, Gong YZ, Zhang HF, Zhang C. Effect of Enteral Nutrition on Dextran Sulfate Sodium-Induced Colitis in Rats. J Dig Dis (2011) 12:453\u20138. 10.1111/j.1751-2980.2011.00518.x", "ArticleIdList": ["10.1111/j.1751-2980.2011.00518.x", "22118695"]}, {"Citation": "Day AS. The Impact of Exclusive Enteral Nutrition on the Intestinal Microbiota in Inflammatory Bowel Disease. AIMS Microbiol (2018) 4:584\u201393. 10.3934/microbiol.2018.4.584", "ArticleIdList": ["10.3934/microbiol.2018.4.584", "PMC6613331", "31294235"]}, {"Citation": "Park YH, Kim N, Shim YK, Choi YJ, Nam RH, Choi YJ, et al. . Adequate Dextran Sodium Sulfate-Induced Colitis Model in Mice and Effective Outcome Measurement Method. J Cancer Prev (2015) 20:260\u20137. 10.15430/JCP.2015.20.4.260", "ArticleIdList": ["10.15430/JCP.2015.20.4.260", "PMC4699753", "26734588"]}, {"Citation": "Alam W, Khan H, Shah MA, Cauli O, Saso L. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing. Molecules (2020) 25:4073. \u00a010.3390/molecules25184073", "ArticleIdList": ["10.3390/molecules25184073", "PMC7570692", "32906577"]}, {"Citation": "Bian Y, Dong Y, Sun J, Sun M, Hou Q, Lai Y, et al. . Protective Effect of Kaempferol on LPS- Induced Inflammation and Barrier Dysfunction in a Coculture Model of Intestinal Epithelial Cells and Intestinal Microvascular Endothelial Cells. J Agric Food Chem (2020) 68:160\u20137. \u00a010.1021/acs.jafc.9b06294", "ArticleIdList": ["10.1021/acs.jafc.9b06294", "31825618"]}, {"Citation": "Gomaa EZ. Human Gut Microbiota/Microbiome in Health and Diseases: A Review. Antonie Van Leeuwenhoek (2020) 113:2019\u201340. \u00a010.1007/s10482-020-01474-7", "ArticleIdList": ["10.1007/s10482-020-01474-7", "33136284"]}, {"Citation": "Glassner KL, Abraham BP, Quigley EMM. The Microbiome and Inflammatory Bowel Disease. J Allergy Clin Immunol (2020) 145:16\u201327. 10.1016/j.jaci.2019.11.003", "ArticleIdList": ["10.1016/j.jaci.2019.11.003", "31910984"]}, {"Citation": "Beheshti A, Shahrokh S, Ansari S, Mirsamadi ES, Yadegar A, Mirjalali H, et al. . Gut Mycobiome: The Probable Determinative Role of Fungi in IBD Patients. Mycoses (2021) 64:468\u201376. \u00a010.1111/myc.13238", "ArticleIdList": ["10.1111/myc.13238", "33421192"]}, {"Citation": "Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS. Alterations of Mucosal Microbiota in the Colon of Patients With Inflammatory Bowel Disease Revealed by Real Time Polymerase Chain Reaction Amplification of 16S Ribosomal Ribonucleic Acid. Indian J Med Res (2015) 142:23\u201332. 10.4103/0971-5916.162091", "ArticleIdList": ["10.4103/0971-5916.162091", "PMC4557246", "26261163"]}, {"Citation": "Shin N-R, Whon TW, Bae J-W. Proteobacteria: Microbial Signature of Dysbiosis in Gut Microbiota. Trends Biotechnol (2015) 33:496\u2013503. 10.1016/j.tibtech.2015.06.011", "ArticleIdList": ["10.1016/j.tibtech.2015.06.011", "26210164"]}, {"Citation": "Chen X, Zuo Q, Hai Y, Sun XJ. Lactulose: An Indirect Antioxidant Ameliorating Inflammatory Bowel Disease by Increasing Hydrogen Production. Med Hypotheses (2011) 76:325\u20137. 10.1016/j.mehy.2010.09.026", "ArticleIdList": ["10.1016/j.mehy.2010.09.026", "21036483"]}, {"Citation": "Xie J, Liu Y, Chen B, Zhang G, Ou S, Luo J, et al. . Ganoderma Lucidum Polysaccharide Improves Rat DSS-Induced Colitis by Altering Cecal Microbiota and Gene Expression of Colonic Epithelial Cells. Food Nutr Res (2019) 63:1559. 10.29219/fnr.v63.1559", "ArticleIdList": ["10.29219/fnr.v63.1559", "PMC6387425", "30814921"]}, {"Citation": "Zhang Y, Wu Z, Liu J, Zheng Z, Li Q, Wang H, et al. . Identification of the Core Active Structure of a Dendrobium Officinale Polysaccharide and its Protective Effect Against Dextran Sulfate Sodium-Induced Colitis Via Alleviating Gut Microbiota Dysbiosis. Food Res Int (2020) 137:109641. 10.1016/j.foodres.2020.109641", "ArticleIdList": ["10.1016/j.foodres.2020.109641", "33233220"]}, {"Citation": "Sidebottom AM, Chang EB. IBD Microbial Metabolome: The Good, Bad, and Unknown. Trends Endocrinol Metab (2020) 31:807\u20139. \u00a010.1016/j.tem.2020.05.001", "ArticleIdList": ["10.1016/j.tem.2020.05.001", "32456844"]}, {"Citation": "Coelho AI, Berry GT, Rubio-Gozalbo ME. Galactose Metabolism and Health. Curr Opin Clin Nutr Metab Care (2015) 18:422\u20137. 10.1097/MCO.0000000000000189", "ArticleIdList": ["10.1097/MCO.0000000000000189", "26001656"]}, {"Citation": "Liew G, Lei Z, Tan G, Joachim N, Ho IV, Wong TY, et al. . Metabolomics of Diabetic Retinopathy. Curr Diabetes Rep (2017) 17:102. \u00a010.1007/s11892-017-0939-3", "ArticleIdList": ["10.1007/s11892-017-0939-3", "28940103"]}, {"Citation": "Strasser B, Sperner-Unterweger B, Fuchs D, Gostner JM. Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms. Inflammation-Associated Depression: Evidence, Mechanisms and Implications. Curr Top Behav Neurosci (2016) 31:95\u2013115. 10.1007/7854_2016_23", "ArticleIdList": ["10.1007/7854_2016_23", "27278641"]}, {"Citation": "Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, et al. . Multidonor Intensive Faecal Microbiota Transplantation for Active Ulcerative Colitis: A Randomised Placebo-Controlled Trial. Lancet (2017) 389:1218\u201328. 10.1016/S0140-6736(17)30182-4", "ArticleIdList": ["10.1016/S0140-6736(17)30182-4", "28214091"]}, {"Citation": "Bo TB, Zhang XY, Kohl KD, Wen J, Tian SJ, Wang DH. Coprophagy Prevention Alters Microbiome, Metabolism, Neurochemistry, and Cognitive Behavior in a Small Mammal. ISME J (2020) 14:2625\u201345. 10.1038/s41396-020-0711-6", "ArticleIdList": ["10.1038/s41396-020-0711-6", "PMC7490276", "32632263"]}, {"Citation": "Kawai T, Akira S. Toll-Like Receptors and Their Crosstalk With Other Innate Receptors in Infection and Immunity. Immunity (2011) 34:637\u201350. 10.1016/j.immuni.2011.05.006", "ArticleIdList": ["10.1016/j.immuni.2011.05.006", "21616434"]}, {"Citation": "Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting Inflammation\u2014the Negative Regulation of NF-\u03baB and the NLRP3 Inflammasome. Nat Immunol (2017) 18:861\u20139. 10.1038/ni.3772", "ArticleIdList": ["10.1038/ni.3772", "28722711"]}, {"Citation": "Kuzmich NN, Sivak KV, Chubarev VN, Porozov YB, Savateeva-Lyubimova TN, Peri F. TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis. Vaccines (2017) 5:34. \u00a010.3390/vaccines5040034", "ArticleIdList": ["10.3390/vaccines5040034", "PMC5748601", "28976923"]}, {"Citation": "Yu P, Ke C, Guo J, Zhang X, Li B. Lactobacillus Plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-KappaB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis. Front Immunol (2020) 11:575173. \u00a010.3389/fimmu.2020.575173", "ArticleIdList": ["10.3389/fimmu.2020.575173", "PMC7566170", "33123156"]}, {"Citation": "Li Y, Yang S, Lun J, Gao J, Gao X, Gong Z, et al. . Inhibitory Effects of the Lactobacillus Rhamnosus GG Effector Protein HM0539 on Inflammatory Response Through the TLR4/MyD88/NF-Small Ka, CyrillicB Axis. Front Immunol (2020) 11:551449. \u00a010.3389/fimmu.2020.551449", "ArticleIdList": ["10.3389/fimmu.2020.551449", "PMC7573360", "33123130"]}, {"Citation": "Huang S, Fu Y, Xu B, Liu C, Wang Q, Luo S, et al. . Wogonoside Alleviates Colitis by Improving Intestinal Epithelial Barrier Function Via the MLCK/pMLC2 Pathway. Phytomedicine (2020) 68:153179. \u00a010.1016/j.phymed.2020.153179", "ArticleIdList": ["10.1016/j.phymed.2020.153179", "32062328"]}, {"Citation": "Lechuga S, Naydenov NG, Feygin A, Cruise M, Ervasti JM, Ivanov AI. Loss of Beta-Cytoplasmic Actin in the Intestinal Epithelium Increases Gut Barrier Permeability In Vivo and Exaggerates the Severity of Experimental Colitis. Front Cell Dev Biol (2020) 8:588836. \u00a010.3389/fcell.2020.588836", "ArticleIdList": ["10.3389/fcell.2020.588836", "PMC7644907", "33195251"]}, {"Citation": "Veenstra JP, Vemu B, Tocmo R, Nauman MC, Johnson JJ. Pharmacokinetic Analysis of Carnosic Acid and Carnosol in Standardized Rosemary Extract and the Effect on the Disease Activity Index of DSS-Induced Colitis. Nutrients (2021) 13:773. \u00a010.3390/nu13030773", "ArticleIdList": ["10.3390/nu13030773", "PMC7997407", "33673488"]}, {"Citation": "Feng Y, Huang Y, Wang Y, Wang P, Song H, Wang F. Antibiotics Induced Intestinal Tight Junction Barrier Dysfunction is Associated With Microbiota Dysbiosis, Activated NLRP3 Inflammasome and Autophagy. PloS One (2019) 14:e0218384. \u00a010.1371/journal.pone.0218384", "ArticleIdList": ["10.1371/journal.pone.0218384", "PMC6581431", "31211803"]}, {"Citation": "Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S. Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction. Am J Nephrol (2013) 38:99\u2013103. 10.1159/000353764", "ArticleIdList": ["10.1159/000353764", "23887095"]}, {"Citation": "Kyuno D, Takasawa A, Kikuchi S, Takemasa I, Osanai M, Kojima T. Role of Tight Junctions in the Epithelial-to-Mesenchymal Transition of Cancer Cells. Biochim Biophys Acta Biomembr (2020) 1863(3):183503. \u00a010.1016/j.bbamem.2020.183503", "ArticleIdList": ["10.1016/j.bbamem.2020.183503", "33189716"]}, {"Citation": "Markov AG, Aschenbach JR, Amasheh S. Claudin Clusters as Determinants of Epithelial Barrier Function. IUBMB Life (2015) 67:29\u201335. 10.1002/iub.1347", "ArticleIdList": ["10.1002/iub.1347", "25788154"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "12"}, {"Year": "2021", "Month": "7", "Day": "8"}, {"Year": "2021", "Month": "8", "Day": "9", "Hour": "6", "Minute": "30"}, {"Year": "2021", "Month": "8", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34367139", "PMC8339999", "10.3389/fimmu.2021.679897"]}}], "PubmedBookArticle": []}